Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

News Physiol Sci 8: 245-248, 1993;
1548-9213/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keidar, S.
Right arrow Articles by Aviram, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Keidar, S.
Right arrow Articles by Aviram, M.

News in Physiological Sciences, Vol 8, 245-248, Copyright © 1993 by International Union of Physiological Sciences

ARTICLES

Angiotensin II Enhances Lipid Peroxidation of Low-Density Lipoprotein

S Keidar, JG Brook and M Aviram

Hypertensive patients demonstrate accelerated atherosclerosis, and angiotensin II has been suggested to play an important role in this phenomenon. Data are presented on the stimulatory effects of angiotensin II on the production of oxidized low-density lipoprotein and on macrophage foam cell formation.


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Keidar, R. Heinrich, M. Kaplan, T. Hayek, and M. Aviram
Angiotensin II Administration to Atherosclerotic Mice Increases Macrophage Uptake of Oxidized LDL: A Possible Role for Interleukin-6
Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1464 - 1469.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Hayek, J. Attias, R. Coleman, S. Brodsky, J. Smith, J. L. Breslow, and S. Keidar
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice
Cardiovasc Res, December 1, 1999; 44(3): 579 - 587.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. de las Heras, P. Aragoncillo, R. Maeso, S. Vazquez-Perez, J. Navarro-Cid, M. DeGasparo, J. Mann, L. M. Ruilope, V. Cachofeiro, and V. Lahera
AT1 Receptor Antagonism Reduces Endothelial Dysfunction and Intimal Thickening in Atherosclerotic Rabbits
Hypertension, October 1, 1999; 34(4): 969 - 975.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. Bouriquet, M. Dupont, A. Herizi, A. Mimran, and D. Casellas
Preglomerular Sudanophilia in L-NAME Hypertensive Rats : Involvement of Endothelin
Hypertension, March 1, 1996; 27(3): 382 - 391.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Keidar, M. Kaplan, and M. Aviram
Angiotensin II–Modified LDL Is Taken Up by Macrophages Via the Scavenger Receptor, Leading to Cellular Cholesterol Accumulation
Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 97 - 105.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online